[精准医学增强了心脏病学中的个性化医学]
G Hasenfuß1,2, A Schuster3,4, L Bergau3,4
1Herzzentrum Göttingen, Klinik für Kardiologie und Pneumologie, Universitätsmedizin Göttingen, Georg-August-Universität, Robert-Koch-Str. 40, 37075, Göttingen, Deutschland. hasenfus@med.uni-goettingen.de.
Innere Medizin (Heidelberg, Germany)
|January 31, 2024
概括
个性化医疗使用患者数据和心脏护理指南. 精准医学通过先进的成像和奥米克技术提供了更深入的见解,而数字技术可以增强未来的心血管治疗.
科学领域:
- 心脏病学 心脏病学
- 基因组学就是基因组学.
- 数字健康数字健康
背景情况:
- 个性化和精准医学往往被混为一谈,但是在医疗保健中的不同方法.
- 心脏病医学目前利用基于临床表现,风险因素和标准诊断的个性化.
- 需要先进的技术来进一步完善患者特定的心血管护理.
研究的目的:
- 在心血管疾病的背景下,要区分个性化和精准医学.
- 概述心脏病学准确医学目前的应用和未来的潜力.
- 突出基因组学,奥米克学和数字技术在推进心血管保健方面的作用.
主要方法:
- 对个性化心脏病医学当前实践的审查.
- 探索精密心脏病学的先进诊断工具,包括创新的成像和omics.
- 评估数字健康技术和大数据的潜在影响.
主要成果:
- 心脏病医学中的个性化依赖于临床数据,风险因素和基于指南的子组分析.
- 精准医学通过先进的成像 (心肌结构,冠状动脉形态,电生理学) 来增强个性化.
- 基因组,转录组和代谢组分析对于罕见的单遗传性疾病至关重要,对复杂的心血管疾病具有未来的潜力;数字技术提供了显著的前景.
结论:
- 个性化和精准医学之间的明确区分对于推进心血管保健至关重要.
- 精准医学,利用先进的诊断和omics,提供比目前的个性化更深入的患者特定见解.
- 数字技术和大数据将彻底改变心血管精密医学,改善诊断,预防和治疗.
相关概念视频
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
167
Receptor tyrosine kinase inhibitors (TKIs) and calcium channel blockers (CCBs) are two critical categories of drugs employed in the treatment of pulmonary artery hypertension (PAH). PAH is a disease that causes high blood pressure in the pulmonary arteries, resulting in chest pain, fatigue, and shortness of breath.
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
167


